Organoids And Spheroids Market To Reach $6.27 Billion By 2030

April 2025 | Report Format: Electronic (PDF)

Organoids And Spheroids Market Growth & Trends

The global organoids and spheroids market size is expected to reach USD 6.27 billion by 2030, registering a CAGR of 23.23% from 2025 to 2030, according to a new report by Grand View Research, Inc., A rise in the adoption of organoid cultures in drug discovery, and rising demand for cell therapy and tissue engineering across the globe is expected to drive the market.

3D spheroids are considered as an important aspect of tissue engineering and regenerative medicine research as they can be used as building blocks for the generation of complex tissues and organs. In addition, the potential of 3D cell cultures to be used as models for drug screening and analysis of human disorders are expected to provide ample growth opportunities to the market in the near future.

A rise in the adoption of organoid cultures for the assessment of the mechanism of human-specific disorders is expected to enhance the market growth. For instance, human organoids have helped in the analysis of a wide range of tissues including the small intestine, prostate, brain, and liver. The promise of the generation of 3D cell cultures that resemble human organs has brought an enormous potential for the use of organoids as cell therapies, and as prospective substitutes for whole-organ transplantation.

Request a free sample copy or view report summary: Organoids and Spheroids Market Report

Organoids And Spheroids Market Report Highlights

Based on type, the organoids segment led the market with the largest revenue share of 59.65% in 2024. The organoid market is primarily driven by the increasing demand for physiologically relevant 3D cell culture models in drug discovery, disease modeling, and personalized medicine.
Based on application, the developmental biology segment led the market with the largest revenue share of 30.17% in 2024, owing to the rising usage of organoid and spheroid culture systems for developmental biology.
Based on end use, the biotechnology and pharmaceutical industries segment led the market with the largest revenue share of 46.32% in 2024.
North America dominated the organoids and spheroids market with the largest revenue share of 34.72% in 2024.

Organoids And Spheroids Market Segmentation

Grand View Research has segmented the global organoids and spheroids market on the basis of type, application, end use, and region:

Organoids And Spheroids Type Outlook (Revenue, USD Million, 2018 - 2030)

By Type
- Organoids
  - By Type
    - Neural Organoids
    - Hepatic Organoids
    - Intestinal Organoids
    - Other Organoids
  - By Method
    - General Submerged Method for Organoid Culture
    - Crypt Organoid Culture Techniques
    - Air Liquid Interface (ALI) Method for Organoid Culture
    - Clonal Organoids from Lgr5+ Cells
    - Brain and Retina Organoid Formation Protocol
    - Other
  - By Source
    - Primary Tissues
    - Stem Cells
- Spheroids
  - By Type
    - Multicellular tumor spheroids (MCTS)
    - Neurospheres
    - Mammospheres
    - Hepatospheres
    - Embryoid bodies
  - By Method
    - Micropatterned Plates
    - Low Cell Attachment Plates
    - Hanging Drop Method
    - Others
  - By Source
    - Cell Line
    - Primary Cell
    - iPSCs Derived Cells